| BPSCX | DFFVX | BPSCX / DFFVX | |
| Total Expense Ratio | 1.26 | 0.29 | 434% |
| Annual Report Gross Expense Ratio | 1.30 | 0.30 | 433% |
| Fund Existence | 28 years | 26 years | - |
| Gain YTD | 1.155 | 10.933 | 11% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 704M | 14.1B | 5% |
| Annual Yield % from dividends | 0.54 | 1.65 | 33% |
| Returns for 1 year | -0.16 | 9.69 | -2% |
| Returns for 3 years | 4.16 | 43.10 | 10% |
| Returns for 5 years | 0.53 | 69.56 | 1% |
| Returns for 10 years | 27.75 | 99.20 | 28% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AHLT | 27.23 | 0.59 | +2.20% |
| American Beacon AHL Trend ETF | |||
| MUNY | 103.20 | -0.07 | -0.07% |
| Vanguard New York Tx-Exm Bd ETF | |||
| PBE | 83.82 | -0.34 | -0.40% |
| Invesco Biotechnology & Genome ETF | |||
| WNTR | 38.48 | -0.68 | -1.74% |
| YieldMax MSTR Short Option Income Strategy ETF | |||
| TSLY | 39.38 | -1.33 | -3.27% |
| YieldMax TSLA Option Income Strategy ETF | |||